Identification of TLR4 as the receptor that recognizes shiga toxins in human neutrophils

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4748-4758

  Brigotti, Maurizio ^a   Carnicelli, Domenica ^a   Arfilli, Valentina ^a   Tamassia, Nicola ^b   Borsetti, Francesca ^a   Fabbri, Elena ^a   Tazzari, Pier Luigi ^a   Ricci, Francesca ^a   Pagliaro, Pasqualepaolo ^a   Spisni, Enzo ^a   Cassatella, Marco A ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN 1; VEROTOXIN 2; CERAMIDE TRIHEXOSIDE; CYTOKINE; GLOBOTRIAOSYLCERAMIDE; MONOCLONAL ANTIBODY; TLR4 PROTEIN, HUMAN;

ARTICLE; BINDING COMPETITION; CELL INTERACTION; CELL STIMULATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MOLECULAR DYNAMICS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HEMOLYTIC UREMIC SYNDROME; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ANTIBODIES, MONOCLONAL; CYTOKINES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LIPOPOLYSACCHARIDES; NEUTROPHILS; SHIGA TOXIN 1; SHIGA TOXIN 2; TOLL-LIKE RECEPTOR 4; TRIHEXOSYLCERAMIDES;

EID: 84886030991     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300122     Document Type: Article

References (82)

1. Trompeter, R. S., R. Schwartz, C. Chantler, M. J. Dillon, G. B. Haycock, R. Kay, and T. M. Barratt. 1983. Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch. Dis. Child. 58: 101-105.
2. Griffin, P. M., and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13: 60-98.
3. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin- producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086.
4. Bielaszewska, M., A. Mellmann, W. Zhang, R. Köck, A. Fruth, A. Bauwens, G. Peters, and H. Karch. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11: 671-676.
5. Frank, C., D. Werber, J. P. Cramer, M. Askar, M. Faber, M. van der Heiden, H. Bernard, A. Fruth, R. Prager, A. Spode, et al.; HUS Investigation Team. 2011. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N. Engl. J. Med. 365: 1771-1780.
6. Rasko, D. A., D. R. Webster, J. W. Sahl, A. Bashir, N. Boisen, F. Scheutz, E. E. Paxinos, R. Sebra, C. S. Chin, D. Iliopoulos, et al. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N. Engl. J. Med. 365: 709-717.
7. Scheutz, F., E. M. Nielsen, J. Frimodt-Møller, N. Boisen, S. Morabito, R. Tozzoli, J. P. Nataro, and A. Caprioli. 2011. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill. 16: (24).
8. Fraser, M. E., M. M. Chernaia, Y. V. Kozlov, and M. N. James. 1994. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat. Struct. Biol. 1: 59-64.
9. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin. Microbiol. Rev. 11: 450-479.
10. Bauwens, A., J. Betz, I. Meisen, B. Kemper, H. Karch, and J. Müthing. 2013. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell. Mol. Life Sci. 70: 425-457.
11. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney, and T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268: 15484-15488.
12. Van Setten, P. A., V. W. van Hinsbergh, L. P. Van den Heuvel, T. J. van der Velden, N. C. van de Kar, R. J. Krebbers, M. A. Karmali, and L. A. Monnens. 1997. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J. Am. Soc. Nephrol. 8: 1877-1888.
13. Hughes, A. K., P. K. Stricklett, and D. E. Kohan. 1998. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int. 54: 426-437.
14. Hughes, A. K., P. K. Stricklett, and D. E. Kohan. 2001. Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells. Nephron 88: 14-23.
15. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171: 45-50.
16. Barbieri, L., P. Valbonesi, M. Brigotti, L. Montanaro, F. Stirpe, and S. Sperti. 1998. Shiga-like toxin I is a polynucleotide:adenosine glycosidase. Mol. Microbiol. 29: 661-662.
17. Brigotti, M., R. Alfieri, P. Sestili, M. Bonelli, P. G. Petronini, A. Guidarelli, L. Barbieri, F. Stirpe, and S. Sperti. 2002. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J. 16: 365-372.
18. Iordanov, M. S., D. Pribnow, J. L. Magun, T. H. Dinh, J. A. Pearson, S. L. Chen, and B. E. Magun. 1997. Ribotoxic stress response: activation of the stressactivated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol. Cell. Biol. 17: 3373-3381.
19. Matussek, A., J. Lauber, A. Bergau, W. Hansen, M. Rohde, K. E. Dittmar, M. Gunzer, M. Mengel, P. Gatzlaff, M. Hartmann, et al. 2003. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 102: 1323-1332.
20. Brigotti, M., D. Carnicelli, E. Ravanelli, A. G. Vara, C. Martinelli, R. R. Alfieri, P. G. Petronini, and P. Sestili. 2007. Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin. Infect. Immun. 75: 2201-2207.
21. Morigi, M., M. Galbusera, S. Gastoldi, M. Locatelli, S. Buelli, A. Pezzotta, C. Pagani, M. Noris, M. Gobbi, M. Stravalaci, et al. 2011. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J. Immunol. 187: 172-180.
22. Tesh, V. L. 2012. Activation of cell stress response pathways by Shiga toxins. Cell. Microbiol. 14: 1-9.
23. Tesh, V. L. 2012. The induction of apoptosis by Shiga toxins and ricin. Curr. Top. Microbiol. Immunol. 357: 137-178.
24. Orth, D., A. B. Khan, A. Naim, K. Grif, J. Brockmeyer, H. Karch, M. Joannidis, S. J. Clark, A. J. Day, S. Fidanzi, et al. 2009. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J. Immunol. 182: 6394-6400.
25. Ståhl, A. L., L. Sartz, A. Nelsson, Z. D. Békássy, and D. Karpman. 2009. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS ONE 4: e6990.
26. Ståhl, A. L., L. Sartz, and D. Karpman. 2011. Complement activation on plateletleukocyte complexes and microparticles in enterohemorrhagic Escherichia coliinduced hemolytic uremic syndrome. Blood 117: 5503-5513.
27. Cooling, L. L., K. E. Walker, T. Gille, and T. A. Koerner. 1998. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect. Immun. 66: 4355-4366.
28. Karpman, D., D. Papadopoulou, K. Nilsson, A. C. Sjögren, C. Mikaelsson, and S. Lethagen. 2001. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97: 3100-3108.
29. Ghosh, S. A., R. K. Polanowska-Grabowska, J. Fujii, T. Obrig, and A. R. Gear. 2004. Shiga toxin binds to activated platelets. J. Thromb. Haemost. 2: 499-506.
30. Fernandez, G. C., S. A. Gomez, M. V. Ramos, L. V. Bentancor, R. J. FernandezBrando, V. I. Landoni, L. Lopez, F. Ramirez, M. Diaz, M. Alduncin, et al. 2007. The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome. Pediatr. Res. 61: 123-128.
31. Brigotti, M. 2012. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 4: 157-190.
32. Walters, M. D., I. U. Matthei, R. Kay, M. J. Dillon, and T. M. Barratt. 1989. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr. Nephrol. 3: 130-134.
33. Milford, D. V., C. M. Taylor, B. Guttridge, S. M. Hall, B. Rowe, and H. Kleanthous. 1990. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch. Dis. Child. 65: 716-721.
34. Coad, N. A., T. Marshall, B. Rowe, and C. M. Taylor. 1991. Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin. Nephrol. 35: 10-16.
35. te Loo, D. M., L. A. Monnens, T. J. van Der Velden, M. A. Vermeer, F. Preyers, P. N. Demacker, L. P. van Den Heuvel, and V. W. van Hinsbergh. 2000. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95: 3396-3402.
36. Brigotti, M., D. Carnicelli, E. Ravanelli, S. Barbieri, F. Ricci, A. Bontadini, A. E. Tozzi, G. Scavia, A. Caprioli, and P. L. Tazzari. 2008. Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol. 84: 1019-1027.
37. Te Loo, D. M., V. W. van Hinsbergh, L. P. van den Heuvel, and L. A. Monnens. 2001. Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J. Am. Soc. Nephrol. 12: 800-806.
38. Brigotti, M., P. L. Tazzari, E. Ravanelli, D. Carnicelli, L. Rocchi, V. Arfilli, G. Scavia, F. Minelli, F. Ricci, P. Pagliaro, et al. 2011. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome. Pediatr. Infect. Dis. J. 30: 486-490.
39. Macher, B. A., and J. C. Klock. 1980. Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J. Biol. Chem. 255: 2092-2096.
40. Griener, T. P., G. L. Mulvey, P. Marcato, and G. D. Armstrong. 2007. Differential binding of Shiga toxin 2 to human and murine neutrophils. J. Med. Microbiol. 56: 1423-1430.
41. Arfilli, V., D. Carnicelli, L. Rocchi, F. Ricci, P. Pagliaro, P. L. Tazzari, and M. Brigotti. 2010. Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. Biochem. J. 432: 173-180.
42. Brigotti, M., D. Carnicelli, V. Arfilli, L. Rocchi, F. Ricci, P. Pagliaro, P. L. Tazzari, A. G. Vara, M. Amelia, F. Manoli, and S. Monti. 2011. Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1. J. Biol. Chem. 286: 34514-34521.
43. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
44. Creagh, E. M., and L. A. O'Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27: 352-357.
45. Ryd, M., H. Alfredsson, L. Blomberg, A. Andersson, and A. A. Lindberg. 1989. Purification of Shiga toxin by alpha-D-galactose-(1-4)-beta-D-galactose(1- 4)-beta-D-glucose-(1-) receptor ligand-based chromatography. FEBS Lett. 258: 320-322.
46. Cassatella, M. A., R. Cappelli, V. Della Bianca, M. Grzeskowiak, S. Dusi, and G. Berton. 1988. Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology 63: 499-506.
47. van Setten, P. A., L. A. Monnens, R. G. Verstraten, L. P. van den Heuvel, and V. W. van Hinsbergh. 1996. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88: 174-183.
48. Dunn-Siegrist, I., O. Leger, B. Daubeuf, Y. Poitevin, F. Dépis, S. Herren, M. Kosco-Vilbois, Y. Dean, J. Pugin, and G. Elson. 2007. Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J. Biol. Chem. 282: 34817-34827.
49. Tazzari, P. L., F. Ricci, D. Carnicelli, A. Caprioli, A. E. Tozzi, G. Rizzoni, R. Conte, and M. Brigotti. 2004. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Cytometry B Clin. Cytom. 61: 40-44.
50. Brigotti, M., A. Caprioli, A. E. Tozzi, P. L. Tazzari, F. Ricci, R. Conte, D. Carnicelli, M. A. Procaccino, F. Minelli, A. V. Ferretti, et al 2006. Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome. J. Clin. Microbiol. 44: 313-317.
51. Vignali, D. A. 2000. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243: 243-255.
52. Cassatella, M. A., V. Huber, F. Calzetti, D. Margotto, N. Tamassia, G. Peri, A. Mantovani, L. Rivoltini, and C. Tecchio. 2006. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J. Leukoc. Biol. 79: 123-132.
53. Tamassia, N., V. Le Moigne, M. Rossato, M. Donini, S. McCartney, F. Calzetti, M. Colonna, F. Bazzoni, and M. A. Cassatella. 2008. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J. Immunol. 181: 6563-6573.
54. Scapini, P., J. A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni, and M. A. Cassatella. 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177: 195-203.
55. Antal-Szalmas, P., J. A. Strijp, A. J. Weersink, J. Verhoef, and K. P. Van Kessel. 1997. Quantitation of surface CD14 on human monocytes and neutrophils. J. Leukoc. Biol. 61: 721-728.
56. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61: 3392-3402.
57. Moesby, L., E. W. Hansen, J. D. Christensen, C. H. Høyer, G. L. Juhl, and H. B. Olsen. 2005. Dry and moist heat sterilisation cannot inactivate pyrogenicity of Gram positive microorganisms. Eur. J. Pharm. Sci. 26: 318-323.
58. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165: 618-622.
59. Ostuni, R., I. Zanoni, and F. Granucci. 2010. Deciphering the complexity of Tolllike receptor signaling. Cell. Mol. Life Sci. 67: 4109-4134.
60. Muzio, M., D. Bosisio, N. Polentarutti, G. D'amico, A. Stoppacciaro, R. Mancinelli, C. van't Veer, G. Penton-Rol, L. P. Ruco, P. Allavena, and A. Mantovani. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164: 5998-6004.
61. Cassatella, M. A. 1999. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73: 369-509.
62. Bielaszewska, M., and H. Karch. 2005. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94: 312-318.
63. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84: 1045-1049.
64. Taub, D. D., T. J. Sayers, C. R. Carter, and J. R. Ortaldo. 1995. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155: 3877-3888.
65. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur. J. Immunol. 25: 64-68.
66. Davey, M. S., N. Tamassia, M. Rossato, F. Bazzoni, F. Calzetti, K. Bruderek, M. Sironi, L. Zimmer, B. Bottazzi, A. Mantovani, et al. 2011. Failure to detect production of IL-10 by activated human neutrophils. Nat. Immunol. 12: 1017-1018, author reply 1018-1020.
67. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
68. Torgersen, M. L., N. Engedal, A. M. Pedersen, H. Husebye, T. Espevik, and K. Sandvig. 2011. Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells. FEMS Immunol. Med. Microbiol. 61: 63-75.
69. Perera, P. Y., S. N. Vogel, G. R. Detore, A. Haziot, and S. M. Goyert. 1997. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J. Immunol. 158: 4422-4429.
70. Imler, J. L., and J. A. Hoffmann. 2001. Toll receptors in innate immunity. Trends Cell Biol. 11: 304-311.
71. Tamassia, N., V. Le Moigne, F. Calzetti, M. Donini, S. Gasperini, T. Ear, A. Cloutier, F. O. Martinez, M. Fabbri, M. Locati, et al. 2007. The MyD88independent pathway is not mobilized in human neutrophils stimulated via TLR4. J. Immunol. 178: 7344-7356.
72. Amith, S. R., P. Jayanth, S. Franchuk, T. Finlay, V. Seyrantepe, R. Beyaert, A. V. Pshezhetsky, and M. R. Szewczuk. 2010. Neu1 desialylation of sialyl alpha-2,3 linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell. Signal. 22: 314-324.
73. Mita, Y., K. Dobashi, T. Nakazawa, and M. Mori. 2001. Induction of Toll-like receptor 4 in granulocytic and monocytic cells differentiated from HL-60 cells. Br. J. Haematol. 112: 1041-1047.
74. Sabroe, I., S. K. Dower, and M. K. Whyte. 2005. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin. Infect. Dis. 41(Suppl 7): S421-S426.
75. Visintin, A., A. Mazzoni, J. H. Spitzer, D. H. Wyllie, S. K. Dower, and D. M. Segal. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166: 249-255.
76. Hayashi, F., T. K. Means, and A. D. Luster. 2003. Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-2669.
77. Elson, G., I. Dunn-Siegrist, B. Daubeuf, and J. Pugin. 2007. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109: 1574-1583.
78. Brigotti, M., P. L. Tazzari, E. Ravanelli, D. Carnicelli, S. Barbieri, L. Rocchi, V. Arfilli, G. Scavia, F. Ricci, A. Bontadini, et al. 2010. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J. Leukoc. Biol. 88: 201-210.
79. Borregaard, N., O. E. Sørensen, and K. Theilgaard-Mönch. 2007. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28: 340-345.
80. Vallés, P. G., S. Melechuck, A. González, W. Manucha, V. Bocanegra, and R. Vallés. 2012. Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome. Pediatr. Nephrol. 27: 407-415.
81. Schröder, N. W., and R. R. Schumann. 2005. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5: 156-164.
82. Mockenhaupt, F. P., J. P. Cramer, L. Hamann, M. S. Stegemann, J. Eckert, N. R. Oh, R. N. Otchwemah, E. Dietz, S. Ehrhardt, N. W. Schröder, et al. 2006. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. USA 103: 177-182.